Hostname: page-component-89b8bd64d-ksp62 Total loading time: 0 Render date: 2026-05-08T14:13:10.633Z Has data issue: false hasContentIssue false

Immediate impact of the COVID-19 pandemic on CTSA TL1 and KL2 training and career development

Published online by Cambridge University Press:  29 June 2020

Wayne T. McCormack*
Affiliation:
Clinical & Translational Science Institute, Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA
Miriam A. Bredella
Affiliation:
Harvard Catalyst, The Harvard Clinical and Translational Science Center, Harvard Medical School, Boston, MA, USA
David H. Ingbar
Affiliation:
Clinical and Translational Science Institute Research Education, Career Development, and Training Core, Department of Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA
Rebecca D. Jackson
Affiliation:
The Center for Clinical and Translational Science, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
Emma A. Meagher
Affiliation:
Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Cynthia D. Morris
Affiliation:
Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA
Joan D. Nagel
Affiliation:
National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA
Susan Pusek
Affiliation:
NC TraCS Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Doris M. Rubio
Affiliation:
Institute for Clinical Research Education, Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA
Kathryn Sandberg
Affiliation:
Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA
H. William Schnaper
Affiliation:
Northwestern University Clinical and Translational Sciences (NUCATS) Institute, Northwestern University, Chicago, IL, USA
Joel Tsevat
Affiliation:
Institute for the Integration of Medicine and Science, Center for Research to Advance Community Health, Department of Medicine, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Jason G. Umans
Affiliation:
Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA
Scott McIntosh
Affiliation:
Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
*
Address for correspondence: W. T. McCormack, PhD, University of Florida Clinical & Translational Science Institute, 1249 Center Drive, Room CG-72K, Gainesville, FL 32610-0208, USA. Email: mccormac@ufl.edu
Rights & Permissions [Opens in a new window]

Abstract

Clinical and Translational Science Award (CTSA) TL1 trainees and KL2 scholars were surveyed to determine the immediate impact of the COVID-19 pandemic on training and career development. The most negative impact was lack of access to research facilities, clinics, and human subjects, plus for KL2 scholars lack of access to team members and need for homeschooling. TL1 trainees reported having more time to think and write. Common strategies to maintain research productivity involved time management, virtual connections with colleagues, and shifting to research activities not requiring laboratory/clinic settings. Strategies for mitigating the impact of the COVID-19 pandemic on training and career development are described.

Information

Type
Expedited Report
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Association for Clinical and Translational Science 2020
Figure 0

Fig. 1. Graphic representation of the relative numbers by state of TL1 trainee and KL2 scholar survey respondents (April 3–13, 2020) and the number of COVID-19 cases (based on Johns Hopkins University data as of April 16, 2020, adapted from reference [13]). Blue circles, TL1 trainees; orange circles, KL2 scholars; gray circles, COVID-19 cases.

Figure 1

Fig. 2. Percentage of respondents indicating high or total impact (4 and 5 on a 5-point Likert scale from 0 = no impact to 5 = total impact). (A) Responses to the question “How are these factors negatively impacting your research?”: personal/mental health, health of loved ones, finances, homeschooling, home environment, access to core facilities, access to laboratory, access to clinic/human research subjects, access to experimental animals, access to supplies, access to team members, access to mentors, graduation timeline. (B) Reponses to the question “What factors have positively impacted your research?”: time to think and write, new research ideas arising from pandemic, and other. Asterisks indicate statistically significant differences between TL1 trainees and KL2 scholars (all P values < 0.05). See Supplemental Tables 1 and 2 for raw data and bivariate statistical analyses.

Figure 2

Fig. 3. Percentage of respondents including each theme in response to the question “What strategies are you implementing to maintain your productivity?” Asterisks indicate statistically significant differences between TL1 trainees and KL2 scholars (P < 0.01). See Supplemental Table 3 for qualitative data, including theme definitions, frequencies, and bivariate statistical analyses.

Supplementary material: File

McCormack et al. supplementary material

Tables S1-S3

Download McCormack et al. supplementary material(File)
File 20.6 KB